keyword
MENU ▼
Read by QxMD icon Read
search

Biogaia

keyword
https://www.readbyqxmd.com/read/27583387/survey-and-evidence-based-review-of-probiotics-used-in-very-low-birth-weight-preterm-infants-within-the-united-states
#1
S Viswanathan, C Lau, H Akbari, C Hoyen, M C Walsh
OBJECTIVE: Data from multiple clinical trials, mostly conducted outside the US, indicate that probiotic prophylaxis is an effective intervention for prevention of necrotizing enterocolitis (NEC) in preterm infants. Probiotics are routinely used in many countries. However, in the US, probiotic use in preterm infants is limited (6.7% of very low birth weight (VLBW) infants in the US were exposed to probiotics in 2014, Vermont Oxford Network (VON)). Probiotic products are often considered in 'generic' terms, but considerable variation exists between commercially available probiotics in terms of their quantity and quality...
December 2016: Journal of Perinatology: Official Journal of the California Perinatal Association
https://www.readbyqxmd.com/read/24829677/probiotic-vs-placebo-in-irritable-bowel-syndrome-a-randomized-controlled-trial
#2
Behnaz Amirimani, Sepideh Nikfam, Maryam Albaji, Sara Vahedi, Siavosh Nasseri-Moghaddam, Maryam Sharafkhah, Reza Ansari, Homyoon Vahedi
BACKGROUND: This study assesses the potential effect of Lactobacillus reuteri as a single strain probiotic preparation (Biogaia®) on irritable bowel syndrome (IBS). METHODS: Patients diagnosed with IBS who fulfilled Rome III criteria and consented to participate in this study were randomized to receive either the probiotic or an identical placebo once daily for four weeks. Patients used a questionnaire to record any symptoms and adverse reactions over a one-week run-in period and during the final two weeks of intervention...
April 2013: Middle East Journal of Digestive Diseases
https://www.readbyqxmd.com/read/22947597/effect-of-routine-probiotic-lactobacillus-reuteri-dsm-17938-use-on-rates-of-necrotizing-enterocolitis-in-neonates-with-birthweight-1000-grams-a-sequential-analysis
#3
COMPARATIVE STUDY
Chelsea Hunter, Mary Ann V T Dimaguila, Peter Gal, John E Wimmer, James Laurence Ransom, Rita Q Carlos, McCrae Smith, Christie C Davanzo
BACKGROUND: Necrotizing enterocolitis (NEC) is a disease in neonates, often resulting in death or serious medical or neurodevelopmental complications. The rate of NEC is highest in the smallest babies and many efforts have been tried to reduce the rate of NEC. In neonates born below 1500 grams, the rate of NEC has been significantly reduced with the use of various probiotics. This study examines the impact of routine use of a probiotic, Lactobacillus reuteri DSM 17938 (BioGaia®), on the rate of NEC in neonates at highest risk for developing NEC, those with birth weight ≤1000 grams...
2012: BMC Pediatrics
https://www.readbyqxmd.com/read/21917706/persistence-of-lactobacillus-reuteri-dsm17938-in-the-human-intestinal-tract-response-to-consecutive-and-alternate-day-supplementation
#4
COMPARATIVE STUDY
Tracey J Smith, Danielle Anderson, Lee M Margolis, Anthony Sikes, Andrew J Young
BACKGROUND: Probiotics may enhance gastrointestinal health and immune function. The efficacy of different probiotic dosing strategies on colonization and persistence of probiotics is undefined. OBJECTIVE: The authors assessed colonization and persistence of Lactobacillus reuteri (L. reuteri) DSM17938 (BioGaia AB, Stockholm, Sweden) after daily or alternate-day dosing. METHODS: Volunteers ate pudding with L. reuteri (10(9) CFU) daily (n = 9) or on alternate days (n = 9) over 7 days...
August 2011: Journal of the American College of Nutrition
https://www.readbyqxmd.com/read/21602611/effect-of-kynurenic-acid-on-the-viability-of-probiotics-in-vitro
#5
Jadwiga Dolecka, Teresa Urbanik-Sypniewska, Barbara Skrzydło-Radomańska, Jolanta Parada-Turska
Probiotics are bacteria that are commercially available as dietary supplements. One of the important properties of probiotics is their ability to survive in the intestine. Recent evidence has identified kynurenic acid (KYNA) as a bactericidal constituent of intestinal fluid. These data led us to study the influence of KYNA on the viability of selected probiotics. We found that KYNA supported the growth of bacteria in the probiotics Acidolac (Lactobacillus acidophilus, Bifidobacterium) and Lakcid Forte (Lactobacillus rhamnosus) or retarded the growth of bacteria from the Acidolac, BioGaia (Lactobacillus reuteri Protectis), Dicoflor (Lactobacillus rhamnosus GG), Lacium (Lactobacillus plantarum) and Trilac (Lactobacillus acidophilus, Lactobacillus delbrueckii subsp...
2011: Pharmacological Reports: PR
https://www.readbyqxmd.com/read/21309653/a-novel-delivery-system-of-probiotic-drop-and-its-effect-on-dental-caries-risk-factors-in-cleft-lip-palate-children
#6
RANDOMIZED CONTROLLED TRIAL
Sule Kavaloglu Cildir, Nuket Sandalli, Serpil Nazli, Fatos Alp, Esber Caglar
OBJECTIVE: The aim of the present study was to investigate the effect of the probiotic bacterium Lactobacillus reuteri on the levels of salivary mutans streptococci and lactobacilli in children with cleft lip/palate who used the novel drop containing L. reuteri. MATERIAL AND METHODS: The study group consisted of 19 operated cleft lip/palate children aged 4 to 12 years. The study had a double-blind, randomized crossover design, and the experimental period consisted of four consecutive time periods...
May 2012: Cleft Palate-craniofacial Journal
https://www.readbyqxmd.com/read/16000808/highly-hydrolytic-reuteransucrase-from-probiotic-lactobacillus-reuteri-strain-atcc-55730
#7
S Kralj, E Stripling, P Sanders, G H van Geel-Schutten, L Dijkhuizen
Lactobacillus reuteri strain ATCC 55730 (LB BIO) was isolated as a pure culture from a Reuteri tablet purchased from the BioGaia company. This probiotic strain produces a soluble glucan (reuteran), in which the majority of the linkages are of the alpha-(1-->4) glucosidic type ( approximately 70%). This reuteran also contains alpha-(1-->6)- linked glucosyl units and 4,6-disubstituted alpha-glucosyl units at the branching points. The LB BIO glucansucrase gene (gtfO) was cloned and expressed in Escherichia coli, and the GTFO enzyme was purified...
July 2005: Applied and Environmental Microbiology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"